Skip to content
Read MoreCauses of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation study: The Lancet Global Health Jan 2025Read MoreComment: The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings by R. Solomons & H. Rabie. Lancet Global Health February 2025. Volume 13, Issue 2e189-e190.
Read MoreThe importance of scale-up: why tackling HIV-linked meningitis is vital to meet the Sustainable Development Goals by Prof David B Meya & Dr Angela LoyseRead MoreD B Meya & G Meintjes HIV-related CNS infections: translating DREAMM into reality. Lancet HIV October 2023 Volume 10, Issue 10e627-e628.Read MoreC. Kanyama et al How to DREAMM and end HIV-related deaths. Lancet Global Health December 2023;11(12):e1857-e1858.Read MoreS G Mfinanga et al Reduction in mortality from HIV-related central nervous system infections in routine care in Africa (DREAMM): A before-and after- implementation study. Lancet HIV October 2023 Volume 10, Issue 10e663-e673.Read MoreDREAMM visual summaryRead MoreRajasingham R, Govender NP, Jordan A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. The Lancet Infectious Diseases. 2022 Dec 1;22(12):1748-55.Read MoreGuidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. World Health Organisation.2022.Read MoreJarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E, Rutakingirwa MK, Ssebambulidde K, Tugume L, Rhein J, Boulware DR. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. New England Journal of Medicine. 2022 Mar 24;386(12):1109-20.
Skip to content
